#	Pagina
attuale pagina	/open-h2020/projects/220172/index.html

Opendata, web and dolomites

PHIVIDIAS

Preclinical Human In Vitro Drug Immune Response Analysis Platform

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

PHIVIDIAS project word cloud

Explore the words cloud of the PHIVIDIAS project. It provides you a very rough idea of what is the project "PHIVIDIAS" about.

immundz innovative computational documents phividias damaged advocate regulatory model market companies molecules feedback disease tissue damage immundnz toxicity interstitial commitment opportunity consequence adverse drug 300 mediated risk fda secondary preclinical tests free immune cells inclusion released services auto small animal variety expressed client ema persons platform drugs networks ignored lung first com approached

Project "PHIVIDIAS" data sheet

The following table provides information about the project.

Coordinator	IMMUNDNZ LIMITED Organization address address: BIOHUB AT ALDERLEY ALDERLEY PARK city: ALDERLEY EDGE postcode: SK10 4TG website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	United Kingdom [UK]
Project website	http://www.immundnz.com
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2019
Duration (year-month-day)	from 2019-01-01 to 2019-06-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	IMMUNDNZ LIMITED IMMUNDNZ LIMITED Organization address address: BIOHUB AT ALDERLEY ALDERLEY PARK city: ALDERLEY EDGE postcode: SK10 4TG website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (ALDERLEY EDGE)	coordinator	50˙000.00

Map

Project objective

Drug-induced tissue damage and the associated risk for developing auto-immune secondary disease is fully ignored in preclinical toxicity testing. As a consequence, there are currently 300 drugs on the market that cause drug-induced auto-immune-mediated interstitial lung disease. In their regulatory documents, EMA and FDA strongly advocate for inclusion of tests to address this type of adverse effects in preclinical research. Immundz (www.immundnz.com) addresses this market opportunity by developing a unique and innovative platform, PHIVIDIAS, for comprehensive preclinical analysis of drug-induced tissue damage and the immune response against molecules released from the damaged cells, together with a computational model for risk assessment for developing auto-immune secondary disease. The testing platform will be animal free. Key persons from the client networks and a variety of other small and large companies have already been approached to assess their interest in the PHIVIDIAS platform. Their feedback identified a significant need for the PHIVIDIAS test platform and a variety of companies expressed their commitment to use the services. With PHIVIDIAS, Immundnz will be first in the market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PHIVIDIAS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PHIVIDIAS" are provided by the European Opendata Portal: CORDIS opendata.